LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

Search

Stevanato Group SpA

Fermé

SecteurSoins de santé

16.01 -1.42

Résumé

Variation du prix de l'action

24h

Actuel

Min

15.88

Max

16.1

Chiffres clés

By Trading Economics

Revenu

10M

49M

Ventes

23M

303M

P/E

Moyenne du Secteur

26.246

110.024

BPA

0.162

Rendement du dividende

0.35

Marge bénéficiaire

16.205

Employés

5,521

EBITDA

10M

73M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+48.47% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

0.35%

2.26%

Prochains Résultats

4 mars 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-2.4B

4.4B

Ouverture précédente

17.43

Clôture précédente

16.01

Sentiment de l'Actualité

By Acuity

50%

50%

141 / 351 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Weak Bullish Evidence

Stevanato Group SpA Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

20 févr. 2026, 17:37 UTC

Acquisitions, Fusions, Rachats

Paramount Regulatory Waiting Period for Warner Bid Expires -- Update

21 févr. 2026, 14:31 UTC

Acquisitions, Fusions, Rachats

Bridgewater Associates' 4Q Buying and Selling -- Barrons.com

21 févr. 2026, 05:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

20 févr. 2026, 23:12 UTC

Acquisitions, Fusions, Rachats

FERC Authorizes TXNM Energy Acquisition by Blackstone Infrastructure

20 févr. 2026, 22:12 UTC

Résultats

Equinox Gold: Announces Filing of 2025 Audited Fincl Statements

20 févr. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

20 févr. 2026, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

20 févr. 2026, 21:23 UTC

Résultats

These Stocks Are Today's Movers: Grail, Corning, Comfort Systems USA, Opendoor, Akamai, Chemours, and More -- Barrons.com

20 févr. 2026, 21:20 UTC

Market Talk

Century Aluminum Backs Trump's Tariffs After SCOTUS Ruling -- Market Talk

20 févr. 2026, 21:01 UTC

Acquisitions, Fusions, Rachats

Want to Win the Warner Bros. Discovery Takeover Battle? 'Walk Away Now.' -- Barrons.com

20 févr. 2026, 20:38 UTC

Market Talk

U.S. Natural Gas Gains Ahead of Chilly Weekend -- Market Talk

20 févr. 2026, 20:17 UTC

Market Talk

Oil Futures Mixed As Market Awaits U.S.-Iran Moves -- Market Talk

20 févr. 2026, 20:11 UTC

Market Talk

Traders Await Word on USMCA Exemption For Trump's Global 10% Tariff -- Market Talk

20 févr. 2026, 19:59 UTC

Market Talk

U.S. Tariff Ruling Could Make Things Worse for Mexico -- Market Talk

20 févr. 2026, 19:58 UTC

Market Talk
Acquisitions, Fusions, Rachats

Netflix Seen as Not Needing Warner Bros. Deal -- Market Talk

20 févr. 2026, 19:49 UTC

Market Talk

Mexico's Revised 4Q GDP Expected to Confirm Pick-Up -- Market Talk

20 févr. 2026, 19:09 UTC

Market Talk

Precious Metals Settle Higher After Tariff Ruling -- Market Talk

20 févr. 2026, 19:00 UTC

Market Talk

U.S. Oil, Gas Rig Counts Unchanged on Week -- Market Talk

20 févr. 2026, 18:28 UTC

Market Talk

Ontario Premier Warns Fight Against U.S. Tariffs Isn't Over -- Market Talk

20 févr. 2026, 18:20 UTC

Market Talk

Tariff Ruling Seen Positive for Some Retailers, Mixed for Others -- Market Talk

20 févr. 2026, 18:05 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

20 févr. 2026, 18:04 UTC

Market Talk

Trade Uncertainty in Canada to Remain Until USMCA Resolved -- Market Talk

20 févr. 2026, 17:38 UTC

Market Talk

Canada's Small Firms Look Toward Increased U.S. Tariff Opposition -- Market Talk

20 févr. 2026, 17:24 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

20 févr. 2026, 17:24 UTC

Market Talk

Correction to Treasury Yields Fall Market Talk

20 févr. 2026, 17:20 UTC

Market Talk

Financial Services Roundup: Market Talk

20 févr. 2026, 16:53 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

20 févr. 2026, 16:53 UTC

Market Talk

Canada Dollar Steady, Market Focus on USMCA Review -- Market Talk

20 févr. 2026, 16:45 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

20 févr. 2026, 16:45 UTC

Market Talk

U.K. Public Finances Supportive of Gilts in Near-Term -- Market Talk

Comparaison

Variation de prix

Stevanato Group SpA prévision

Objectif de Prix

By TipRanks

48.47% hausse

Prévisions sur 12 Mois

Moyen 23.83 USD  48.47%

Haut 30 USD

Bas 17.5 USD

Basé sur 4 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

4 ratings

2

Achat

2

Maintien

0

Vente

Score Technique

By Trading Central

21.56 / 22.61Support & Résistance

Court Terme

Weak Bullish Evidence

Moyen Terme

Weak Bearish Evidence

Long Terme

Bullish Evidence

Sentiment

By Acuity

141 / 351Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Moyen

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Stevanato Group SpA

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
help-icon Live chat